Format

Send to

Choose Destination
Womens Health (Lond). 2008 Nov;4(6):583-94. doi: 10.2217/17455057.4.6.583.

Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome.

Author information

1
Endocrine Unit, First Department of Medicine, Medical Scool, University of Athens, Greece. cchristak@med.uoa.gr

Abstract

Polycystic ovary syndrome (PCOS) is associated with a clustering of metabolic and cardiovascular risk factors. Insulin resistance is implicated as the major player in the metabolic abnormalities and contributes to the increased cardiovascular risk associated with the syndrome. However, androgen excess appears to participate as an independent parameter, which further aggravates the cardiovascular and metabolic aberrations in affected women with PCOS. The resultant impact of hyperandrogenemia possibly acquires clinical significance for women's health in the context of PCOS, particularly since recent data support an increased incidence of coronary artery disease and of cardiovascular events directly related to androgen levels in women with the syndrome.

PMID:
19072461
DOI:
10.2217/17455057.4.6.583
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center